General Motors on Wednesday announced that in 2022 it delivered 2.2 million vehicles in the United States, making it the biggest automaker in the country. 

Toyota took the crown from GM back in 2021, but held onto it for less than two years. The Japanese automaker sold 2.1 million vehicles in 2022, which is down 9.6 percent from 2021. 

Shares of Toyota were down more than 1 percent following the release on Wednesday. 

GM, by comparison, saw its sales increase 2.5 percent from 2021.  A big chunk of those gains came in the fourth quarter, as supply chain issues eased and sales shot up 40 percent year-over-year. Cadillac sales were up 75 percent, and GM Fleet sales jumped 101 percent. 

The legacy automaker isn't resting on its laurels in 2023. GM said it plans to grow its share of the electric vehicle market with a number of battery-powered models. 

"GM plans to build on this momentum in North America in 2023, growing EV market share with nine EV models on sale, including the Chevrolet Bolt EV and Bolt EUV, which was the bestselling mainstream EV series in the third and fourth quarter," the company said in a statement. 

The company said it expects production of the Bolt EV and Bolt EUC to increase to more than 70,000 units this year. Sales of those models were up 64,332 percent in 2022, as GM ramped up production of its electric line. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More